🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Keyu Li

Boston University

ORCID: 0000-0002-4547-4918
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma”.

A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma

Nature Communications(2023)10.1038/s41467-023-39196-9
N/A
1.4DataRank · unranked
87 citations

Carol Judkins, Keyu Li, Su Jin Lim, Jessica Hoare, Rose Parkinson +24 more

Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000351
N/A
0DataRank · unranked
38 citations

May Tun Saung, Hao Jing, Brian Herbst, MacKenzie Zarecki, Stephen Muth +13 more

Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy

Cancer Cell(2022)10.1016/j.ccell.2022.10.001
N/A
0DataRank · unranked
178 citations

Joseph A. Tandurella, Jessica Gai, Qingfeng Zhu, Su Jin Lim, Dwayne L. Thomas +26 more

Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01253-z
N/A
0DataRank · unranked
73 citations

Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas +13 more

Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy

Gastroenterology(2022)10.1053/j.gastro.2022.06.027
N/A
0DataRank · unranked
76 citations

Jianxin Wang, John Davelaar, Andrew Baker, Keyu Li, Nan Niu +17 more

CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma

The Journal of Experimental Medicine(2022)10.1084/jem.20211631
N/A
0DataRank · unranked
65 citations

May Tun Saung, Keyu Li, Juan Fu, Kenji Fujiwara, Nan Niu +17 more

Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.24.563862
N/A
0DataRank · unranked
3 citations

Vanessa Funes, Sanjana Davuluri, Hector E. Ibanez, Wei‐Chih Sun, Juan Fu +14 more

Consensus, debate, and prospective on pancreatic cancer treatments

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01613-x
N/A
0DataRank · unranked
85 citations

Jie Yang, Amol Narang, Jing He, Christopher L. Wolfgang, Keyu Li +2 more

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects

Chronic Diseases and Translational Medicine(2020)10.1016/j.cdtm.2020.01.002
N/A
0DataRank · unranked
70 citations

Jia‐Long Yuan, Diego Trafton, Jianxin Wang, Nan Niu, Chunhui Yuan +3 more

Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration

Journal of Hematology & Oncology(2024)10.1186/s13045-024-01576-z
N/A
0DataRank · unranked
20 citations

Junke Wang, Rui Zhang, Jiawei Zhou, Birginia Espinoza, Nan Niu +18 more